Prolonged door-to-balloon time: is treatment delayed always treatment denied?

Area of Science:

• Cardiology
• Emergency Medicine
• Health Services Research

Background:

• ST-segment elevation myocardial infarction (STEMI) requires rapid reperfusion for optimal outcomes.
• Both fibrinolysis and percutaneous coronary intervention (PCI) reduce STEMI mortality, with earlier application yielding greater benefits.
• PCI is now the primary reperfusion strategy, often favored over fibrinolysis.

Purpose of the Study:

• To examine the established guidelines and clinical practices aimed at accelerating STEMI reperfusion therapy.
• To investigate the reasons for delays in reperfusion therapy for some STEMI patients.
• To question the universal superiority of the fastest reperfusion versus potentially more comprehensive, delayed approaches.

Main Methods:

• Review of existing guidelines and algorithms for STEMI care.
• Analysis of factors contributing to delayed reperfusion in STEMI patients.
• Discussion of the trade-offs between speed and comprehensiveness in reperfusion therapy.

Main Results:

• Guidelines and public reporting of door-to-balloon times incentivize rapid STEMI treatment.
• Delays in reperfusion are often linked to comorbidities or concurrent medical issues in STEMI patients.
• The optimal timing of reperfusion may be influenced by factors beyond just speed.

Conclusions:

• While rapid reperfusion is critical for STEMI, adherence to strict timeframes may not always be feasible or optimal.
• Concurrent medical conditions can complicate rapid reperfusion efforts.
• Further evaluation is needed to determine if delayed, more comprehensive therapy offers advantages in specific STEMI patient populations.